
The Associated Press - 1 December 1995
Federal officials said they will work with Medicaid agencies in Delaware, Florida, New Jersey and Rhode Island to get the message out that the drug AZT can sharply reduce the risk of mothers' passing the virus on to babies in the womb.
The Health Care Financing Administration announced the initiative as part of Friday's eighth World AIDS Day.
"This is something we can do" to combat the epidemic, Dr. Helen L Smits, HCFA's deputy administrator, told a news conference. "We want the message out to every pregnant woman in the country."
Infected women who take AZT for six weeks during pregnancy can reduce the odds of infecting their babies from one in four to one in 12, according to the research published earlier this year by National Institutes of Health.
The project, starting in January, will include distributing videos and brochures to women at grocery stores, hairdressers, churches and other settings in Delaware; offering counseling in jails and county health centers in Florida; mailing information to welfare recipients in New Jersey and working through HMOs and health centers in Rhode Island.
About 7,000 babies are born to HIV-infected women in the United States each year. Medicaid covers 3,000 of those mothers, and many of the rest would qualify if they applied, the government said.
Medicaid also winds up paying the medical bills for nearly 90 percent of children inflicted with AIDS.
The campaign includes a video featuring Roslynn A. Howard, a Baltimore woman who counsels HIV positive women at Johns Hopkins Hospital and is herself infected.
"So far I have not had a woman at my facility turn down AZT," said Howard, who took part in the original study, but received a placebo, not AZT. Her daughter, now 4, is healthy and uninfected.
The U.S. Public Health Service helped produce materials for the campaign. HIV infected women are encouraged to take AZT during the second trimester and delivery, and the babies get it for six weeks.
Copyright 1995/The Associated Press. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, The Associated Press, 50 Rockefeller Plaza, New York, NY 10020.
951201
AP951206
Copyright © 1995 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .